Parkinson's disease as a systemic pathology

Aging (Albany NY). 2019 Feb 11;11(4):1081-1082. doi: 10.18632/aging.101824.

Authors

Mario Ezquerra^{1

2}, María-José Martí^{1

2}, Rubén Fernández-Santiago^{1

2}

Affiliations

¹ Laboratory of Neurodegenerative Disorders, Department of Neurology-Hospital Clínic of Barcelona, IDIBAPS, UB, 08036 Barcelona, Catalonia.
² Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid 28031, Spain.

No abstract available

Keywords: Parkinson’s disease; fibroblasts; transcriptomic.

Publication types

Editorial

MeSH terms

Dopaminergic Neurons / metabolism
Fibroblasts / metabolism
Gene Expression Regulation
Humans
Induced Pluripotent Stem Cells / metabolism
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / genetics
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / metabolism
Mutation
Parkinson Disease / metabolism*
Parkinson Disease / pathology*

Substances

LRRK2 protein, human
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2